The cheapest way to get a GLP-1, priced route by route

The five routes, priced

People search for the cheapest GLP-1 as though it were a property of the drug. It isn’t. The same medication, the same dose, the same week, costs $25 or $499 depending entirely on which of five routes you are eligible for — and the biggest savings come from moving between routes, not from haggling within one.

Two of those five are closed to most people the moment they read them: the savings card requires commercial insurance that covers the drug, and the Bridge requires Medicare Part D. That is not a technicality. It is the single biggest determinant of what you will pay, which is why the tool above asks about insurance before it asks about anything else.

The cheapest GLP-1 without insurance

This is the question behind most searches in this category, and the answer has changed. For two years the reflexive answer was “compounded semaglutide from a telehealth subscription”. On published prices, that is no longer true.

The cheapest published route to an FDA-approved GLP-1, for someone paying cash, is a tablet bought straight from the manufacturer — and it undercuts all but one of the compounded subscription totals we were able to derive.

Three things about that table are worth saying plainly, because they are what turn it into a decision:

• The tablet is the cheap one. At $149 a month, Wegovy tablets are the lowest published self-pay price for any FDA-approved product in this class, tied with Foundayo’s tablet at the same figure — half the price of the same drug in a pen. If cost is the constraint, that is the conversation to have with your prescriber.
• Buying direct still needs a prescription. Self-pay pricing is not the same as no-prescription. If you already see a doctor, getting one may cost you nothing extra; if you don’t, add whatever a visit costs — one directory provider publishes $129 for a visit without insurance, which is the kind of figure to budget against.
• The discounted ceilings you see quoted elsewhere need insurance you do not have. Zepbound is widely published as $299 to $449 by dose, and both halves of that range come with a condition. The $449 is a purchase offer that lapses unless each refill is completed within 45 days, and the card behind it requires commercial insurance that does not cover Zepbound — which is a real situation, and not the one you are in if you have no insurance at all. Lilly’s regular price at the maintenance doses is $699. If you are paying cash with no plan behind you, that is your number, and it is the one this table now prints.
• Two of these figures expire, and the table says which. Wegovy pens are $199 only for a new patient’s first two fills, and Foundayo’s 2.5 mg and 5.5 mg doses are temporarily discounted — all three revert on 31 December 2026. A price that ends is not the same kind of fact as a price that holds, which is why every row carries the date it was read rather than sharing one caption between them.

The cheapest GLP-1 with insurance

If your plan covers the medication, nothing on this page beats it. Both manufacturers advertise as little as $25 a month for people with commercial insurance using the savings card. Two caveats decide whether that figure is real for you:

• Your plan has to cover the drug at all. Many employer plans exclude weight-management medications as a whole category, separately from the formulary. That exclusion is the thing to check first, before tiers and copays.
• The card is capped. Savings are limited — $100 a month on the Novo card, and $100 a month with a $1,300 annual ceiling on the Zepbound card — so a large copay is only partly offset, not erased.

The cost and coverage guide walks the whole insurance pathway, including what to do when a prior authorisation is denied — denials are frequently overturned when the prescriber supplies clinical documentation, and an appeal is usually worth more than switching to a cheaper drug.

Affordable online GLP-1 providers, compared on what you’re billed

We costed 18 published pricing options across the 15 providers in our telehealth directory, adding each company’s membership or programme fee to its medication price to get a monthly total. The comparison sits in the tool above, where you can switch between a steady month, your first month, and year one.

Two findings from doing that arithmetic are worth stating on their own:

• 10 of the 18 options could be totalled; 8 could not. Not because we didn’t look, but because the provider publishes a membership fee and then does not publish what the medication costs on top of it — or publishes two figures that cannot be reconciled. Those entries carry no total, and the reason is shown in place of a number.
• The cheapest headline is rarely the cheapest total. A $79 membership beside a $99 medication is a $178 month. A $19.99 membership with the medication billed separately is not a $19.99 month at all — it is a $19.99 month plus an amount nobody has told you yet.

The 8 we could not total, and what was missing

Naming these is the point rather than an admission. A comparison that quietly drops the providers whose figures do not add up looks more complete than it is, and the reader who most needs the warning is the one considering exactly those providers. Each line below is the provider’s own wording for the component we could not price.

Noom Med — Telehealth-only plan plus a brand-name medication

Brand-name Wegovy or Zepbound is billed separately; Noom does not publish a price for it.

WeightWatchers Clinic — Clinic membership on the longest term

Not included in the membership; cost depends on pharmacy and insurance, and WeightWatchers does not publish a figure.

Amazon One Medical — Cash-pay oral GLP-1 through the One Medical programme

A One Medical membership is required for the full programme; the programme announcement we checked does not publish that fee as a figure. On-demand renewals for an existing prescription are published at $29 (message) or $49 (video).

PlushCare — Membership plus a visit, uninsured

Billed separately by the pharmacy. PlushCare does not publish a medication price, because it does not set one.

Calibrate — The Metabolic Reset, medication billed to insurance

Calibrate bills medication and labs to the member's own insurance and publishes no cash price. It states GLP-1 copays for most commercially insured members are typically $25/month or less once any deductible is met.

Sesame — A GLP-1 programme listing, no membership

Wegovy is advertised from $199/month on some listings, but what any given listing includes is set by the individual clinician, so there is no platform-wide medication price to add.

Fella Health — Compounded semaglutide on an annual plan

Fella Health publishes a $199–$449/month membership that includes coaching, and separately advertises compounded semaglutide from $99/month on a $1,188 annual prepay. Its published figures do not say whether the medication price sits inside the membership or on top of it, so there is no monthly total here we would stand behind.

Willow Health — Compounded tirzepatide

Willow Health does not publish a stable price list, so there is nothing here to total. A provider that will not tell you the price before you sign up is itself a finding.

If you already know which drug you want

Everything above answers the question by route: which way of paying costs least for someone in your situation. That answer is much the same whichever GLP-1 you end up on, which is why this page does not split by drug.

If you have already settled on a molecule, the question changes shape — it becomes which forms of that drug exist and who supplies them, and there the two most common answers genuinely diverge. Semaglutide is the only one you can take as a tablet, and 6 providers in our directory name it as a compounded option. Tirzepatide has no approved oral form at all, and 3 name it. So the detail lives on its own page for each:

• What semaglutide costs, by the form you take it in — injection, tablet and compounded, priced side by side, with the tablet coming out lowest of every approved option in the class.
• What tirzepatide costs — why the price floor is set by injection, how the device changes the figure, and where the April 2025 litigation sits.

The cheapest GLP-1 pill, and what it costs once you are past the first dose

3 FDA-approved GLP-1 tablets carry a published self-pay price, and every one of them starts at the same figure: $149 a month. That is the number every page quoting a “cheapest GLP-1 pill” gives, including ours further up, and it is correct. It is also the price of the lowest dose in a ladder, which is the part that usually goes unsaid.

Titration is not optional and it is not a failure — every product in this class is started low and increased, because that is how the side effects are made tolerable. So the dose you are on in month one is the dose you are meant to leave. Read the right-hand column as the price of the thing working, and the left as the price of starting it. On Foundayo that is a difference of $200 a month between the figure in the advertisement and the figure at the top of the ladder.

Which changes how the pill compares with a needle. The cheapest published self-pay GLP-1 shot is the Zepbound KwikPen at $299 a month for its starting dose. That is below the $349 a month the tablets reach at the top of their ladder — so a starting injection undercuts a maintenance tablet, and “the pill is the cheap one” stops being true somewhere on the way up. But the injections climb further than the tablets do. The Zepbound KwikPen is $699 a month at its maintenance doses, $350 above the highest published tablet price, so the form you choose matters most at exactly the doses people stay on.

One thing the table cannot show: Rybelsus is a third approved semaglutide tablet and has no published self-pay price at all. It is absent because there is nothing to put in the cell, which is the finding rather than an omission.

What “from $99 a month” leaves out

Every advertised price in this category is a real number attached to a narrow condition. The gap between it and your card statement is made of five things, and they stack.

1. 01

   The membership, billed separately

   The most common structure is a monthly membership for access to a prescriber, plus the medication charged on top. Advertising usually leads with whichever of the two is smaller.

2. 02

   The annual prepay behind the lowest rate

   Several of the lowest monthly figures are annual-prepay rates. One provider’s $99-a-month compounded semaglutide is $1,188 paid upfront; another’s $74 membership is the twelve-month rate against $149 month-to-month. Ask what the month-to-month price is, and what happens to the prepayment if you stop.

3. 03

   The month after the introductory offer

   First-month pricing of $25 to $39 is common and is usually a fraction of the standing rate. Budget on month two. In the tool above, the “your first month” view exists precisely so you can see how far apart the two are.

4. 04

   The dose you end up on

   Doses climb during titration by design — see how titration works for why. Some providers price flat across dose increases and say so; manufacturer self-pay pricing generally does not, with Zepbound KwikPen published at $299 at the starting dose and $699 at its maintenance doses. A price quoted at the starting dose is not a price for the year.

5. 05

   The units the price is quoted in

   A four-week supply is not a calendar month. Thirteen of them fit in a year rather than twelve, which quietly adds a supply’s cost to your annual total without changing the advertised monthly figure at all.

A GLP-1 with no membership fee at all

Enough people search for this specifically that it is worth answering on its own terms, because it is a different objection from the price being high. A membership is a recurring charge that continues whether or not you are prescribed anything that month, and most people asking have already been caught by one.

Of the 18 costings we hold, 4 publish a price with no separate membership or programme fee attached — nothing is charged on top of what is quoted:

• Found — Coaching membership plus a compounded GLP-1. Published from $169 a month.
• Noom Med — The Microdose GLP-1Rx tier, medication included. Published from $179 a month.
• Delilah — The bundled programme. Published from $239 a month.
• Henry Meds — Compounded oral semaglutide. Published from $249 a month.

Now the part that matters, because it is the opposite of what the question assumes. Every one of those is more expensive than the cheapest option that does charge a fee. The lowest monthly total on this page is $139 at Mochi Health, and it includes a membership. Avoiding a fee and paying less are different goals, and on current published prices they point at different providers.

There is also a category the question tends to miss. The routes that do not involve a telehealth company at all carry no membership by definition — buying direct from the manufacturer, using a savings card through insurance, or the Medicare bridge programme. Two national pharmacy chains now belong on that list as well, since Walgreens and CVS both prescribe for a per-visit fee instead. Buying direct is published from $149 a month and charges no fee of any kind, which makes it both the fee-free option and close to the cheapest for someone paying cash for an approved product.

What a course costs, not what a month costs

Every comparison in this category answers “how much per month”. That question has a clean answer and it is the wrong one, because two things move underneath it — and both come from the sellers’ own pricing pages rather than from us.

The price changes while you are still climbing

NovoCare states plainly that self-pay pricing “varies by dose”. For the Wegovy pen that means $199 a month for a new patient’s first two fills and $349 a month afterwards. The advertised figure is the price of exactly two months out of twelve.

Wegovy pen, self-pay direct from NovoCare advertises $199 and averages $324 a month across year one — 63% higher. Nothing about that is hidden: it is stated on the page the advertised figure comes from. It is simply never multiplied out, and the titration tracker shows why the introductory tier runs out long before you reach the dose the trials measured.

The cheapest rates are the ones you pay for upfront

Several of the lowest monthly figures on this page are annual-prepay or minimum-commitment rates. They are genuinely the cheapest option if you finish the term. Most people do not: Prime Therapeutics found 15% of people who start a GLP-1 for obesity are still taking one at two years, and 8% at three.

A prepaid year is only cheap if you finish it. Eight in a hundred are still taking a GLP-1 three years in.

This is not an argument against prepaying, and it is certainly not a prediction that you will stop. It is the second number that belongs beside the first: a plan advertised at $99 a month costs $396 a month if you use three months of it. Ask what happens to the balance before you pay it, because the answer varies by provider and is rarely on the pricing page.

Compounded is cheaper. Here is exactly what you trade for it.

Compounded semaglutide and tirzepatide are the reason the cheap end of this market exists. They are also not the same product as the approved drug, and the difference is not a technicality about branding.

What that means for a price decision: a compounded subscription can be genuinely cheaper per month than a brand-name one, but it is bought outside the FDA approval system, it is not covered by insurance, and the supply channel it depends on may narrow. The gap has also closed almost entirely: the cheapest compounded total we can derive is $139 a month against $149 for either approved tablet bought direct. Saving a few dollars a month is a different proposition from the one this market offered two years ago, when the same trade was worth hundreds.

There is no over-the-counter GLP-1, and “GLP-1 supplements” are not GLP-1s

A large share of the searching behind this page is for something that does not exist: an over-the-counter GLP-1, a GLP-1 without a prescription, a GLP-1 pill you can buy on a shelf. The honest answer is short. Every FDA-approved GLP-1 receptor agonist is prescription-only. No supplement contains one.

Products marketed as GLP-1 “supplements”, “boosters”, or “activators” are a different category of product entirely. They are not GLP-1 receptor agonists, they are not reviewed before sale the way a drug is, and the comparison to a prescribed medication is a marketing device rather than a clinical one. Whatever they may or may not do, they are not a cheaper version of the thing on this page.

“GLP-1 near me”: what local access actually changes

Not the price, mostly. A local clinic changes who evaluates you and what that evaluation costs; the medication is dispensed under national manufacturer pricing or your plan’s terms either way. Where locality decides everything is availability — compounded products are unavailable in several states, and telehealth companies are licensed state by state.

The full version of that answer, and the sequence it belongs to, is now its own page: where to actually buy a GLP-1, and the four decisions it runs through. If you have a regular doctor, that remains the cheapest route to a prescription and the only one that costs nothing to ask about.

An HSA or FSA changes the price of every route above

None of the figures on this page account for how you pay them, and one payment method changes all of them at once. GLP-1 medications prescribed for an approved use are generally an eligible medical expense under a health savings account or flexible spending account, so paying from one uses pre-tax money. That does not lower the price a provider charges — it lowers what the price costs you, by roughly your marginal tax rate, and it applies to the cash routes as readily as to a copay.

Two practical points sit behind that. Providers differ on whether they accept these cards directly, and the ones that do tend to say so in their own terms rather than in their pricing — it is a field worth checking on a provider’s own record before you assume it. And eligibility follows the prescription: an account administrator may ask for a letter of medical necessity, which is a conversation to have with the prescriber rather than the provider.

We have not priced this as a route of its own because the saving depends on your tax position, and inventing an example rate would put a number on this page that is nobody in particular’s. What it is worth checking is whether your plan offers one at all, before comparing anything above.

One route is deliberately absent from every table above. Overseas and Canadian pharmacies advertise heavily against US prices, and the FDA’s published position is that importing for personal use is illegal in most circumstances — the two conditions GLP-1s fail, and why advertising to Americans is itself disqualifying, set out separately rather than priced here.

How often these figures actually move

Every price on this page carries the date we read it, which is only useful if you know how quickly a date goes stale. So here is the record: every change we have logged to the prices, terms and legal position of the providers and manufacturers on this page, plotted against when it happened and separated by how we came to know about it.

The bottom row is the one that costs something to produce. Those entries exist because a provider quietly changed a figure and somebody re-read the page and noticed — there was no announcement to pick up. Two of them are corrections to our own earlier work rather than changes at a provider, which is why they are in the log with everything else instead of being fixed silently.

The figures themselves are kept as a dated series rather than only as a current snapshot, so the question “has this got cheaper” has somewhere to be answered: what each price was when we read it, and which announced changes have not landed yet. It is published as licensed data as well as as a page.

How to keep a cheap price cheap

These medications generally need to be taken long-term to maintain their effect, so the number that matters is not the first month’s price but the twelfth. Four things protect it:

• Ask what happens at the next dose. Flat pricing across dose increases is a real feature, and providers that offer it publish it.
• Read the cancellation terms before paying for a year. The prepay discount is only a discount if you finish the year.
• Re-check your route annually. Formularies change at open enrolment, and a plan that excluded the drug class last year may not this year.
• Watch the list price change. Novo Nordisk announced on 24 February 2026 that the list price of Wegovy, Ozempic, and Rybelsus falls to $675 a month from 1 January 2027. Novo Nordisk states the change does not affect direct-to-patient self-pay prices. It matters most if you are paying a coinsurance percentage of the list price rather than a flat copay.

One more, which is a clinical point rather than a financial one: if you stop for cost reasons, appetite generally returns, because the effect depends on the drug being present. That is worth raising with a prescriber before you commit to a price you cannot sustain — see how these medications work.

Questions people ask about cheap GLP-1s

Where can I get the most affordable GLP-1 medication?

It depends on how you are paying, and the answer is a route rather than a place. With commercial insurance that covers the drug, a manufacturer savings card through your own pharmacy is cheapest. On Medicare, it is the GLP-1 Bridge programme. Paying cash for an FDA-approved product, it is buying direct from the manufacturer's own pharmacy rather than through any telehealth company. Telehealth subscriptions are cheapest only for compounded medication, which is a different product with different trade-offs.

Which GLP-1 is cheapest?

The drug is not really the variable — the route you buy it through is. The same medication can differ by several hundred dollars a month depending on whether it is billed to insurance, bought direct from the manufacturer, or supplied through a telehealth membership. That said, among FDA-approved products the lowest published cash price is for tablets rather than injections, and among compounded preparations semaglutide is generally cheaper than tirzepatide because more suppliers offer it.

Is there a GLP-1 under $100 a month?

Not on any published price we have been able to verify. The lowest published cash price for an FDA-approved GLP-1 is $149 a month, and the lowest complete monthly total we could derive for a compounded telehealth option is $139. Both are above $100. Prices advertised below that figure generally quote either an introductory first month, a membership fee that excludes the medication, or a product that contains no GLP-1 drug at all.

What is the cheapest GLP-1?

The cheapest GLP-1 is decided by who is paying, not by which drug you choose. With commercial insurance that covers the medication, a manufacturer savings card brings it to as little as $25 a month. On Medicare, the GLP-1 Bridge programme is a flat $50 a month for eligible Part D enrollees on covered products. Paying cash, the lowest published price for an FDA-approved product is $149 a month for Wegovy tablets bought direct from NovoCare Pharmacy.

What is the cheapest GLP-1 without insurance?

Buying direct from the manufacturer is the cheapest approved route: NovoCare publishes Wegovy tablets from $149 a month and Eli Lilly publishes Foundayo from $149, with injection pens from $299. One compounded telehealth total comes in slightly under that — around $139 a month once Mochi Health's membership is added to its medication price — but a compounded preparation has not been reviewed for identity, purity or sterility, and that programme bills per four-week supply rather than per month. You still need a prescription either way, which costs whatever your prescriber charges.

Is there an over-the-counter GLP-1?

No. Every FDA-approved GLP-1 receptor agonist is prescription-only, and no over-the-counter product contains one. Products sold as GLP-1 supplements, boosters, or activators are not GLP-1 receptor agonists and are not held to the same standard for what they contain.

Can you get a GLP-1 without a doctor's prescription?

Not legally, and not safely. A prescription requires an evaluation by a licensed clinician, which a legitimate telehealth service will carry out before prescribing. Sites that sell GLP-1 products with no evaluation are operating outside the regulated supply chain, and research-chemical peptide sellers state their products are not intended for human use.

What does a GLP-1 pill cost?

Two of them share it, and both are tablets. Wegovy tablets are $149 a month self-pay from NovoCare Pharmacy, and Foundayo — Eli Lilly's orforglipron tablet — is also from $149 a month through LillyDirect, for its 0.8 mg dose. Together those are the lowest published self-pay price for any FDA-approved GLP-1, injections included. Foundayo's price is dose-tiered above that: $199 at 2.5 mg and $299 higher up.

What is the cheapest GLP-1 programme?

Programme is doing work in that question that price alone does not answer. A telehealth programme bundles the prescriber, the medication and usually some coaching into one recurring charge, so the cheapest programme and the cheapest medication are rarely the same thing — the lowest programme fees tend to attach to compounded products, and the lowest medication prices tend to come from buying direct from the manufacturer, where there is no programme at all. Comparing them means adding the membership to the medication for each one, which is what the comparison on this page does, and refusing to total the ones that do not publish both halves.

Why are the prices on Reddit lower than the ones here?

Usually because they are a different kind of number. A figure in a forum is what one person paid, once, which can legitimately be lower than any published price: an introductory fill, a coupon, a dose someone was still titrating through, a plan that covered more than they expected, or a purchase from a source that does not publish prices because it should not be selling. Every figure on this page is one we read on the seller's own page on a stated date, which is reproducible and therefore comparable, and which is also why it will look higher. Treat a forum price as a lead to check rather than a rate you can ask for.

Why is compounded semaglutide so much cheaper?

Because it is not the FDA-approved product. Compounded semaglutide and tirzepatide are not reviewed by the FDA for safety, effectiveness, or manufacturing quality, and they are not covered by insurance. The FDA proposed in April 2026 to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list, which would end large-scale compounded supply from that channel; a final decision was still pending as of August 2026.

Does a cheap telehealth membership include the medication?

Usually not. Most telehealth pricing has two parts — a membership or programme fee and the medication — and the advertised figure is often only one of them. Of the published pricing options we costed across our provider directory, several could not be totalled at all, because the provider publishes a membership fee and then does not publish what the medication costs on top of it.

Are GLP-1 prices about to fall?

One published list price is. Novo Nordisk announced on 24 February 2026 that the list price of Wegovy, Ozempic, and Rybelsus falls to $675 a month from 1 January 2027. The company states this does not change its direct-to-patient self-pay prices, which are already lower than that.

Where to go from here

• Get matched to a providerFour questions, a shortlist from the same directory, no referral fee at any point.
• The full provider directoryAll 15 providers with their disclosures, litigation flags, and state coverage — unranked and alphabetical.
• Your insurance cost pathwayWhat your specific coverage means, savings-programme eligibility, and how to appeal a denial.
• Microdosing, and why it is cheaperSeveral low-cost tiers are microdose products. No randomised trial has tested them.

This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.